Latest Form 4 insider transactions

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on September 28, 2026.

Trump Media & Technology Group Corp. and TAE Technologies, Inc. have amended their convertible promissory note and filed a Form S-4 registration statement, moving forward with their proposed merger.

Skyworks Solutions has received all necessary regulatory clearances for its proposed combination with Qorvo, Inc., with an expected closing date of October 5, 2026.

Skyworks Solutions has received all necessary regulatory clearances for its proposed combination with Qorvo, Inc., with an expected closing date of October 5, 2026.

Sizzle Acquisition Corp. II announced an amendment to its Business Combination Agreement with Trasteel Holding S.A., extending a key deadline and clarifying post-closing board composition.

Joseph P. Davy, Chief Executive Officer, a Director and 10% owner of Banzai International, Inc., purchased 115,965 shares of common stock on September 28, 2026.

Leon Recanati, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.

Nir Nimrodi, a Director of Evogene Ltd., received 10,000 shares of common stock on September 4, 2026.

Electra AI announces new customer wins and strategic collaborations, bolstering its position ahead of its business combination with Iron Horse Acquisition II Corp.

Adrian John Percy, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.

Dan Michael Falk, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.

Aperture AC's subsidiary, Atlantic HPC Group Inc., has acquired Valley Oasis Development LLC, adding 29 MW of contracted power capacity in Tennessee to its digital infrastructure platform.

Peoples Bancorp Inc. and Capital Bancorp, Inc. announced a definitive agreement for Peoples to acquire Capital in an all-stock transaction valued at approximately $728.1 million, creating a larger, more diversified financial services franchise.

Robert John Andrew Ryan, a Director of ASP Isotopes Inc., purchased 8,000 shares of common stock on 2026-09-28-05:00 for $2.70 per share.

Hector W Alila, a Director of Caring Brands, Inc., received 50,000 shares of common stock on September 28, 2026.

Christopher Melton, a Director of Caring Brands, Inc., received 50,000 shares of common stock on September 28, 2026.

Christopher Matthew Galeta, a Director of Caring Brands, Inc., received 25,000 shares of common stock on September 28, 2026.

Tsai-Chun Pan, Group Vice President of Tencent Music Entertainment Group, reported multiple transactions in common stock on September 29, 2026.

Jordan Wu, President, CEO and a Director of Himax Technologies, Inc., reported multiple transactions in common stock on September 30, 2026.

Pete O'Heeron, COB, Secretary, Treasurer, a Director and 10% owner of Liberty Star Uranium & Metals Corp., purchased 257,223 shares of common stock on September 28, 2026 for $0.02 per share.

Brian Meadows, Chief Financial Officer of Caring Brands, Inc., received 25,000 shares of common stock on September 28, 2026.

Ming-Feng Pan, Chief Financial Officer of Himax Technologies, Inc., reported multiple transactions in common stock on September 30, 2026.

OceanLight Acquisition Corporation has entered into a definitive agreement to merge with AIRE Inc., a home textile and green sleep technology company, in a transaction valuing AIRE at $1 billion.

Repligen and BioLife provide supplemental disclosures regarding their merger, including details on executive compensation, ongoing litigation, and the upcoming BioLife stockholder meeting.

Repligen and BioLife provide supplemental disclosures regarding their merger, including details on executive compensation, ongoing litigation, and the upcoming BioLife stockholder meeting.

Jingjing Eason Zhang, VP and Chief Financial Officer of MINISO Group Holding Ltd, purchased 150,600 shares of common stock on September 29, 2026 for $2.26 per share.

Vishwas Seshadri, Chief Executive Officer and a Director of Abeona Therapeutics Inc., sold 19,608 shares of common stock on September 29, 2026 for $5.16 per share.

Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics Inc., sold 9,191 shares of common stock on September 29, 2026 for $5.16 per share.

Brendan M. O'Malley, SVP, Chief Legal Officer of Abeona Therapeutics Inc., sold 6,727 shares of common stock on September 29, 2026 for $5.16 per share.

Madhav Vasanthavada, Chief Commercial Officer of Abeona Therapeutics Inc., sold 4,902 shares of common stock on September 29, 2026 for $5.16 per share.